Sottnik JL - Search Results

1

Activation of the Wnt pathway through AR79, a GSK3β inhibitor, promotes prostate cancer growth in soft tissue and bone.

Jiang Y, Dai J, Zhang H, Sottnik JL, Keller JM, Escott KJ, Sanganee HJ, Yao Z, McCauley LK, Keller ET. Jiang Y, et al. Among authors: sottnik jl. Mol Cancer Res. 2013 Dec;11(12):1597-610. doi: 10.1158/1541-7786.MCR-13-0332-T. Epub 2013 Oct 2. Mol Cancer Res. 2013. PMID: 24088787 Free PMC article.

2

Understanding and targeting osteoclastic activity in prostate cancer bone metastases.

Sottnik JL, Keller ET. Sottnik JL, et al. Curr Mol Med. 2013 May;13(4):626-39. doi: 10.2174/1566524011313040012. Curr Mol Med. 2013. PMID: 23061677 Free PMC article. Review.

3

Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of β-catenin activation of the DKK1 promoter in prostate cancer.

Zhang H, Yu C, Dai J, Keller JM, Hua A, Sottnik JL, Shelley G, Hall CL, Park SI, Yao Z, Zhang J, McCauley LK, Keller ET. Zhang H, et al. Among authors: sottnik jl. Oncogene. 2014 May 8;33(19):2464-77. doi: 10.1038/onc.2013.203. Epub 2013 Jun 10. Oncogene. 2014. PMID: 23752183 Free PMC article.

4

Tumor-induced pressure in the bone microenvironment causes osteocytes to promote the growth of prostate cancer bone metastases.

Sottnik JL, Dai J, Zhang H, Campbell B, Keller ET. Sottnik JL, et al. Cancer Res. 2015 Jun 1;75(11):2151-8. doi: 10.1158/0008-5472.CAN-14-2493. Epub 2015 Apr 8. Cancer Res. 2015. PMID: 25855383 Free PMC article.

5

Integrin alpha2beta 1 (α2β1) promotes prostate cancer skeletal metastasis.

Sottnik JL, Daignault-Newton S, Zhang X, Morrissey C, Hussain MH, Keller ET, Hall CL. Sottnik JL, et al. Clin Exp Metastasis. 2013 Jun;30(5):569-78. doi: 10.1007/s10585-012-9561-6. Epub 2012 Dec 15. Clin Exp Metastasis. 2013. PMID: 23242739 Free PMC article.

6

Wnt and Wnt inhibitors in bone metastasis.

Sottnik JL, Hall CL, Zhang J, Keller ET. Sottnik JL, et al. Bonekey Rep. 2012 Jul 4;1:101. doi: 10.1038/bonekey.2012.101. eCollection 2012. Bonekey Rep. 2012. PMID: 23951488 Free PMC article.

7

The PCa Tumor Microenvironment.

Sottnik JL, Zhang J, Macoska JA, Keller ET. Sottnik JL, et al. Cancer Microenviron. 2011 Dec;4(3):283-97. doi: 10.1007/s12307-011-0073-8. Epub 2011 Jul 5. Cancer Microenviron. 2011. PMID: 21728070 Free PMC article.

8

Osteocytes serve as a progenitor cell of osteosarcoma.

Sottnik JL, Campbell B, Mehra R, Behbahani-Nejad O, Hall CL, Keller ET. Sottnik JL, et al. J Cell Biochem. 2014 Aug;115(8):1420-9. doi: 10.1002/jcb.24793. J Cell Biochem. 2014. PMID: 24700678 Free PMC article.

9

Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma.

Grivas PD, Daignault S, Tagawa ST, Nanus DM, Stadler WM, Dreicer R, Kohli M, Petrylak DP, Vaughn DJ, Bylow KA, Wong SG, Sottnik JL, Keller ET, Al-Hawary M, Smith DC, Hussain M. Grivas PD, et al. Among authors: sottnik jl. Cancer. 2014 Mar 1;120(5):692-701. doi: 10.1002/cncr.28477. Epub 2013 Nov 18. Cancer. 2014. PMID: 24249435 Free article. Clinical Trial.

10

Mediator of DNA Damage Checkpoint 1 (MDC1) Is a Novel Estrogen Receptor Coregulator in Invasive Lobular Carcinoma of the Breast.

Sottnik JL, Bordeaux EK, Mehrotra S, Ferrara SE, Goodspeed AE, Costello JC, Sikora MJ. Sottnik JL, et al. Mol Cancer Res. 2021 Aug;19(8):1270-1282. doi: 10.1158/1541-7786.MCR-21-0025. Epub 2021 May 4. Mol Cancer Res. 2021. PMID: 33947745 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters